General
Intravenous iron may boost exercise capacity in iron-deficient HF patients
 

Intravenous iron may boost exercise capacity in iron-deficient HF patients

Shared by:

 
Intravenous ferric carboxymaltose appears to produce a significant improvement in exercise capacity, as measured by peak oxygen consumption (VO2), in symptomatic patients with heart failure (HF) and iron deficiency, according to the results of the EFFECT-HF trial presented at the American Heart Association (AHA) 2016 Scientific Sessions.
 
specialty.mims.com
 
24 Nov 2016 - General